A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension

NCT00779181 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: ADX415
DRUG: ADX415
DRUG: ADX415
DRUG: Placebo

Sponsor

Addrenex Pharmaceuticals, Inc.